+44 (0) 1223 737941 enquiries@cn-bio.com
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
  • Events
  • News
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
CN Bio
  • Home
  • CN Bio
    • The Company
    • Management Team
    • Careers
  • Organ-On-Chip
    • About Organ-On-Chip
    • Liver-On-Chip
    • Barrier Models
    • 3D Cell Culture
    • Toxicology
    • Drug Metabolism
    • Disease Modelling
  • Products & Services
    • PhysioMimix™ OOC
      • Product Information
      • Consumables
      • T12
      • LC12
    • Human Cell Referral
    • NASH Fee-For-Service
    • Drug Metabolism and Safety Toxicity Testing Services
  • Resources
    • Scientific Publications
    • Brochures
    • Videos
  • Contact
Select Page

How a novel in vitro Liver-on-a-Chip model of fatty liver disease is being used to help prevent a global healthcare crisis.

by CN Bio. | Jan 27, 2021 | NASH

Obesity is a global epidemic. Up to a third of the USA’s adult population is now obese and worldwide, the prevalence of obesity has almost tripled since the 1970s. Increased obesity has triggered a wave of serious associated health conditions, notably cardiovascular...

Recent Posts

  • CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research 1st March 2021
  • Flowing to the Beat of Your Heart 17th February 2021
  • How a novel in vitro Liver-on-a-Chip model of fatty liver disease is being used to help prevent a global healthcare crisis. 27th January 2021

Categories

  • Business
  • Media Coverage
  • NASH
  • OOC Blog
  • Press releases
  • Uncategorised
Website built and designed by Website Energizers LTD | © 2021 CN Bio Innovations | Registered No. 06517359 | VAT No. 978184563 | Privacy Policy | Terms | Sitemap